News
More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...
NEW YORK >> More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from ...
Bariatric surgeon Jonathan Carter discusses the pros and cons of surgery compared with GLP-1 drugs. For those with severe ...
A new virtual health program has helped Grand Strand patients lose more than 2,500 pounds in just six months!Since OrthoSC ...
NYC Health + Hospitals/Lincoln announced on July 10 the launch of a new bariatric surgery program meant to give patients ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Thousands of customers are set to receive payments after purchasing a weight loss supplement once described as the “Gastric ...
GLP-1s: To receive GLP-1s, a person must have a BMI of 30 or higher, or lower if they have a weight-related health condition like type 2 diabetes, hypertension or sleep apnea. Weight Loss ...
The Trump administration’s “one big beautiful bill” makes multiple changes to the snap program—including how much state’s will have to contribute in paying for the food stamps. By 2028, the changes in ...
Registered dietitian lost 60 pounds with GLP-1 weight loss drug Wegovy. She shares foods to avoid and prioritize to minimize side effects and muscle loss.
Gov. Jeff Landry struck language from the Louisiana budget plan that could have provided state employees and public school teachers with insurance coverage for popular weight-loss medication over the ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results